Ingen internetforbindelse — viser den gemte version af siden.

AIM ImmunoTech In…

USUSD
← Til Screeneren

AIM ImmunoTech Inc (US:AIM) — Biotechnology: Biological Products (No Diagnostic Substances). Antal børser, hvor selskabets aktier handles: 2. På denne side — kurs og diagram, udbytte, største aktionærer og historik over antal aktier.

Om Virksomheden

Websted
aimimmuno.com
Investorrelationer
aimimmuno.com/investors/
Sektor
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Hovedkontor
OCALA, United States
Administrerende Direktør
Thomas K. Equels
Ansatte
19
Udestående Aktier
30.44 mio. pr. 2026-08-07
Free Float
27.64 mio.
Markedsværdi
7.18 mio. USD
Insidere
0.51%
Institutionelle Investorer
2.88%
Branche (SIC)
Biological Products, (No Diagnostic Substances)
P/E
underskud
FCF
—
Gæld
3.62 mio. USD
nettokasse
Indtjening og FCF — for de 12 måneder frem til 30.06.2026 (virksomhedens seneste rapport).
Beskrivelse

AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. It is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was founded in 1966 and is headquartered in Ocala, Florida.

annonce

Børser og Tickere

BørsTickerValutaPrisType
US USA StocksAIM primærUSD0.1774 -1.44%almindelige aktier
LSE London Stock Exchange0A4Y IOBGBP—almindelige aktier

Kurs over 5 år (ugentlige lys)

stigningsdag faldsdagHold musen over / tryk på en dag — åbnings-, luknings-, højeste og laveste kurs

Nyheder Denne Uge

Pressemeddelelser fra virksomhedens investorhjemmeside, opdateret dagligt. Links fører til virksomhedens hjemmeside. Overskrifterne er på originalsproget, som på virksomhedens hjemmeside.

Største Ejere

EjerAndelAktierRapportdato
KELLNER TED D (Director)≈4.88%3.72 mio.2025-04-11
Jane Street Group, LLC1.06%807 8852026-06-30
MITCHELL WILLIAM M (Dire…≈0.69%522 1032025-04-11
RODINO PETER W III (Chie…≈0.53%401 7622025-04-04
APPELROUTH STEWART L. (D…≈0.51%388 7292024-12-31
BRYAN NANCY K (Director)≈0.38%291 8822025-03-14
Virtu Financial LLC0.16%124 2692026-06-30
EQUELS THOMAS K (Officer…≈0.13%102 8222026-09-16
Morgan Stanley0.07%50 8642026-06-30
Geode Capital Management…0.06%46 0032026-06-30
Fidelity Concord Street…0.06%44 0842026-07-31
Goldman Sachs Group Inc0.04%32 4442026-06-30
UBS Group AG0.04%28 9312026-06-30
CHEMEROW DAVID I (Direct…≈0.04%28 4412026-03-12
Susquehanna Internationa…0.03%21 8592026-06-30
Vanguard Fiduciary Trust…0.02%17 5192026-06-30
Ground Swell Capital, LL…0.02%12 2222026-06-30
Tower Research Capital L…0.01%4 6682026-06-30
Fidelity Concord Street…0%6822026-07-31